Write what you believe about your stocks; every morning the cited record grades it: supported, challenged, or untouched. Never opinions.

← The archive

archived as published

Thursday, 15 October · prices through NSE close

Tata Elxsi reports Q2 revenue growth of 15% year-on-year, and 5 more corroborated developments

1

Tata Elxsi reports Q2 revenue growth of 15% year-on-year

Tata Elxsi reported revenue from operations of Rs 1,055.7 crore for the second quarter of FY27 ended 30 September 2026, representing 3.4% quarter-on-quarter increase and 15% year-on-year growth. Net profit for the quarter stood at Rs 170.3 crore, up 10% year-on-year from Rs 154.8 crore in Q2 FY26, though marginally lower than Rs 170.6 crore in the preceding June quarter.

2

HCL Technologies Q2 profit rises 21 percent year-on-year

HCL Technologies reported consolidated net profit of Rs 5,132 crore in Q2 FY27, representing a 21 percent increase from Rs 4,235 crore in the year-ago period. The quarter also saw revenue of Rs 35,620 crore and record deal bookings of $3.3 billion, with strong advanced AI revenue growth.

3

Billionbrains Garage Ventures profit rises 54% year-on-year

Billionbrains Garage Ventures Ltd, parent company of investment platform Groww, reported consolidated net profit of Rs 725 crore for Q2 FY27, representing a 54 percent year-on-year increase from Rs 471 crore in the same quarter last year. The company posted a marginal sequential decline in revenue and profit for the September quarter.

4

ICICI Life Insurance Q2 profit rises 25 percent

ICICI Life Insurance reported a 25 percent year-on-year increase in net profit to ₹374.22 crore for the second quarter, with net premium income growing 16.6 percent year-on-year to ₹13,803.90 crore. Value of New Business grew approximately 21 percent during the period.

5

Hyundai Motor India invests 11,000 crore in Pune plant

6

RBI conducts overnight reverse repo operations

regulatoryorg.inindiatimes.comthehindubusinessline.com+11+10corroborated · 13 sourcesCited record →

New here? The reader's guide explains every page, plate by plate.

fregime is informational research software. Content on this page is factual reporting compiled from cited public sources; nothing here is advice, and nothing here expresses an opinion on any security. fregime is not registered with SEBI as an investment adviser or research analyst. Before making investment decisions, consult a SEBI-registered adviser. Price figures are delayed end-of-day values cited to the exchange's published file, never live quotes.